コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ent pre-surgical mp-MR followed by MR-guided stereotactic core biopsy.
2 irmed carcinomas preoperatively sampled with stereotactic core biopsy.
3 nd 15 of 195 (7.7%) were diagnosed by FNA or stereotactic core biopsy.
4 ze the site of breast lesions removed during stereotactic core biopsy.
5 were based on Medicare estimates of $472 for stereotactic core biopsy and $1,335 for surgical biopsy.
6 of +385 for US-guided core biopsy, +610 for stereotactic core biopsy, and +1,332 for needle localiza
7 abnormality was inadvertently removed during stereotactic core biopsy, and a 0.5- or 1.0-cm-long endo
8 rwent vacuum-assisted 11- or 14-gauge needle stereotactic core biopsy for calcifications with maligna
9 viewed to determine the frequency with which stereotactic core biopsy obviated a surgical procedure.
12 this series, cost savings were realized with stereotactic core biopsy over open surgical biopsy for a
16 ive and abundant EBV-TK mRNA expression in a stereotactic core biopsy specimen from a solid organ tra
18 cised with surgical biopsy, one with DCIS at stereotactic core biopsy underwent axillary dissection a
20 ich a cancer yielded atypical hyperplasia at stereotactic core biopsy was higher for calcifications t